Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI facility
October 22, 2026

October 22, 2026
October 6, 2026
October 5, 2026
October 1, 2026
September 21, 2026
September 10, 2026
A new initiative to connect and empower early-career pathologists across Europe
September 2, 2026
September 1, 2026
October 22, 2026
A first for both organisations: the first implantable device built by the UK’s national active implant manufacturing facility is Ceryx’s bioelectronic...
October 6, 2026
Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences...
October 5, 2026
Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225